(74) have previously shown increased IL-15 promoter methylation in cutaneous T-cell lymphoma (CTCL), another T-cell malignancy largely driven by IL-15 pathogenesis. This evidence concerns the gene IL15 and primary cutaneous T-cell non-Hodgkin lymphoma.